Kathiawad Today

Abdominal Aortic Aneurysm Market to Exhibit Moderate Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight | Key Companies – AstraZeneca, Merck Serono, CARDIATIS S.A.

 Breaking News
  • No posts were found

Abdominal Aortic Aneurysm Market to Exhibit Moderate Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight | Key Companies – AstraZeneca, Merck Serono, CARDIATIS S.A.

March 22
06:10 2023
Abdominal Aortic Aneurysm Market to Exhibit Moderate Growth Rate During the Forecast Period (2022-2032), Investigates DelveInsight | Key Companies - AstraZeneca, Merck Serono, CARDIATIS S.A.
The Abdominal Aortic Aneurysm market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Abdominal Aortic Aneurysm pipeline products will significantly revolutionize the Abdominal Aortic Aneurysm market dynamics.

DelveInsight’s “Abdominal Aortic Aneurysm Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Abdominal Aortic Aneurysm, historical and forecasted epidemiology as well as the Abdominal Aortic Aneurysm market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Abdominal Aortic Aneurysm market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

 

To Know in detail about the Abdominal Aortic Aneurysm market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Abdominal Aortic Aneurysm Market Insights

 

Abdominal Aortic Aneurysm Overview

Abdominal Aortic Aneurysm (AAA) is a localized enlargement of the abdominal aorta such that the diameter is greater than 3 cm or more than 50% larger than usual. It occurs when atherosclerosis or plaque buildup causes the walls of the abdominal aorta to become weak and bulge outward like a balloon. It develops slowly over time and has few noticeable symptoms. The larger an aneurysm grows, the more likely it will burst or rupture, causing intense abdominal or back pain, dizziness, nausea or shortness of breath.

 

Some of the key facts of the Abdominal Aortic Aneurysm Market Report: 

  • The Abdominal Aortic Aneurysm market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • As per the study conducted by Palma M. Shaw et al. (2019), the prevalence of abdominal aortic aneurysms increases after age 60, and it peaks in the seventh and eighth decades of life
  • As per the study conducted by Anna Hohnecket al.(2019), in 40 of 566 patients (7.1%), AAAs were detectable. 2.5% patients had a first diagnosis of Abdominal Aortic Aneurysm, the remaining 26 patients were either already diagnosed (patients, 2.5%) or previously treated (patients, 2.1%)
  • As per the SVS Guidelines for Abdominal aortic aneurysm (2018) affects approximately 2% to 8% of the population older than 60 years. The prevalence increases rapidly in men after age 55 years and in women after age 70 years
  • Every year, 200,000 people in the U.S. are diagnosed with an abdominal aortic aneurysm (AAA)
  • Key Abdominal Aortic Aneurysm Companies: AstraZeneca, Merck Serono, CARDIATIS S.A., CARDINAL HEALTH, INC., COOK MEDICAL, INC., ENDOLOGIX, INC., jotec gmbh, LOMBARD MEDICAL, INC., MEDTRONIC PLC, nano endoluminal sa, TERUMO CORPORATION, W. L. GORE & ASSOCIATES, INC., and others
  • Key Abdominal Aortic Aneurysm Therapies: Metformin Glucophage, Ticagrelor, and others
  • The Abdominal Aortic Aneurysm epidemiology based on gender analyzed that Abdominal aortic aneurysms are more common in men

 

Get a Free sample for the Abdominal Aortic Aneurysm Market Report –

https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-market

 

Key benefits of the Abdominal Aortic Aneurysm Market report:

  1. Abdominal Aortic Aneurysm market report covers a descriptive overview and comprehensive insight of the Abdominal Aortic Aneurysm Epidemiology and Abdominal Aortic Aneurysm market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Abdominal Aortic Aneurysm market report provides insights on the current and emerging therapies.
  3. Abdominal Aortic Aneurysm market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Abdominal Aortic Aneurysm market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Abdominal Aortic Aneurysm market.

 

Download the report to understand which factors are driving Abdominal Aortic Aneurysm epidemiology trends @ Abdominal Aortic Aneurysm Epidemiological Insights 

 

Abdominal Aortic Aneurysm Market  

The dynamics of the Abdominal Aortic Aneurysm market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

 

Abdominal Aortic Aneurysm Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Abdominal Aortic Aneurysm Epidemiology Segmentation:

The Abdominal Aortic Aneurysm market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Abdominal Aortic Aneurysm
  • Prevalent Cases of Abdominal Aortic Aneurysm by severity
  • Gender-specific Prevalence of Abdominal Aortic Aneurysm
  • Diagnosed Cases of Episodic and Chronic Abdominal Aortic Aneurysm

 

Abdominal Aortic Aneurysm Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Abdominal Aortic Aneurysm market or expected to get launched during the study period. The analysis covers Abdominal Aortic Aneurysm market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Abdominal Aortic Aneurysm Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Discover more about therapies set to grab major Abdominal Aortic Aneurysm market share @ Abdominal Aortic Aneurysm market forecast

 

Abdominal Aortic Aneurysm Therapies and Key Companies

  • Metformin Glucophage: Merck Serono
  • Ticagrelor: AstraZeneca

 

Scope of the Abdominal Aortic Aneurysm Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Abdominal Aortic Aneurysm Companies: AstraZeneca, Merck Serono, CARDIATIS S.A., CARDINAL HEALTH, INC., COOK MEDICAL, INC., ENDOLOGIX, INC., jotec gmbh, LOMBARD MEDICAL, INC., MEDTRONIC PLC, nano endoluminal sa, TERUMO CORPORATION, W. L. GORE & ASSOCIATES, INC., and others
  • Key Abdominal Aortic Aneurysm Therapies: Metformin Glucophage, Ticagrelor, and others
  • Abdominal Aortic Aneurysm Therapeutic Assessment: Abdominal Aortic Aneurysm current marketed and Abdominal Aortic Aneurysm emerging therapies
  • Abdominal Aortic Aneurysm Market Dynamics: Abdominal Aortic Aneurysm market drivers and Abdominal Aortic Aneurysm market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Abdominal Aortic Aneurysm Unmet Needs, KOL’s views, Analyst’s views, Abdominal Aortic Aneurysm Market Access and Reimbursement 

 

Table of Contents 

1. Abdominal Aortic Aneurysm Market Report Introduction

2. Executive Summary for Abdominal Aortic Aneurysm

3. SWOT analysis of Abdominal Aortic Aneurysm

4. Abdominal Aortic Aneurysm Patient Share (%) Overview at a Glance

5. Abdominal Aortic Aneurysm Market Overview at a Glance

6. Abdominal Aortic Aneurysm Disease Background and Overview

7. Abdominal Aortic Aneurysm Epidemiology and Patient Population

8. Country-Specific Patient Population of Abdominal Aortic Aneurysm 

9. Abdominal Aortic Aneurysm Current Treatment and Medical Practices

10. Abdominal Aortic Aneurysm Unmet Needs

11. Abdominal Aortic Aneurysm Emerging Therapies

12. Abdominal Aortic Aneurysm Market Outlook

13. Country-Wise Abdominal Aortic Aneurysm Market Analysis (2019–2032)

14. Abdominal Aortic Aneurysm Market Access and Reimbursement of Therapies

15. Abdominal Aortic Aneurysm Market Drivers

16. Abdominal Aortic Aneurysm Market Barriers

17.  Abdominal Aortic Aneurysm Appendix

18. Abdominal Aortic Aneurysm Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Abdominal Aortic Aneurysm treatment, visit @ Abdominal Aortic Aneurysm Medications

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services